October 2026
1. GUO Z, Kasinathan D, Yun S, Golson ML, et al
   Islet-Targeted ZnT8 Antibodies Protect Pancreatic beta-Cells From Inflammatory Stress.
   Diabetes. 2026;75:1892-1905.
   

   >> Share

   
   
2. CHEN J, Lin Y, Yang Y
   Comment on Amendolara et al. Distinct Interplay Between beta-Cell Function and Insulin Resistance in Latent Autoimmune Diabetes in Adults Versus Type 2 Diabetes.
   Diabetes. 2026;75:e37-e38.
   

   >> Share

   
   
3. AMENDOLARA R, De Vita F, Buzzetti R, Maddaloni E, et al
   Response to Comment on Amendolara et al. Distinct Interplay Between beta-Cell Function and Insulin Resistance in Latent Autoimmune Diabetes in Adults Versus Type 2 Diabetes.
   Diabetes. 2026;75:e39.
   

   >> Share

   
   August 2026
4. HOSTRUP SNF, Croosu SS, Roikjer J, Morch CD, et al
   Accelerated Brain Aging in Type 1 Diabetes Across Painful and Painless Peripheral Neuropathy: MRI-Based Brain Age Estimates From Deep Learning.
   Diabetes. 2026 Aug 11:db260305. doi: 10.2337/db26-0305.
   

   >> Share

   
   
5. SAAVEDRA D, Mittal R, Blaschke C, Rech Tondin A, et al
   The Intersection of Immunosenescence, Cellular Senescence, and Type 1 Diabetes: Paving the Way for Future Interventions.
   Diabetes. 2026 Aug 6:db260159. doi: 10.2337/db26-0159.
   

   >> Share

   
   
6. CHAVEZ MD, Mahr AR, Wilkins HM, Tse HM, et al
   Metabolic Blockade of Glycolysis Diminishes Autoreactive CD4 T-Cell Effector Responses in Type 1 Diabetes.
   Diabetes. 2026 Aug 3:db251152. doi: 10.2337/db25-1152.
   

   >> Share

   
   July 2026
7. ZHANG J, Li M, Zhou X, Ni H, et al
   Myeloid-Specific Heparanase Aggravates Insulitis in Type 1 Diabetes via Heparan Sulfate Fragment-Dependent Amplification of Macrophage Polarization.
   Diabetes. 2026 Jul 31:db260365. doi: 10.2337/db26-0365.
   

   >> Share

   
   
8. BURKETT JB, Fuhr J, Falk AC, Dadi P, et al
   Dual Modulation of Prostaglandin E2 Receptors EP3 and EP4 Protects beta-Cell Mass in a Model of Aggressive Autoimmune Inflammation.
   Diabetes. 2026 Jul 31:db251007. doi: 10.2337/db25-1007.
   

   >> Share

   
   
9. MUKHERJEE N, Millman JR
   Applications of Stem Cell-Derived Islets and Emerging Experimental Platforms to Understand Diabetes.
   Diabetes. 2026 Jul 13:db260013. doi: 10.2337/db26-0013.
   

   >> Share

   
   
10. LI S, Wang J, Xin C, Dong Y, et al
    beta-Hydroxybutyrate Improves Glucose Metabolism in Streptozotocin-Induced Type 1 Diabetes by Inhibiting Gut and Liver Glucose Transporters via GPR109A.
    Diabetes. 2026;75:1125-1141.
    

    >> Share

    
    
11. TRICO D, Jiang L, Spicer D, Page K, et al
    Ketone Bodies Derived From Medium-Chain Triglycerides Support Brain Metabolism and Function Under Hypoglycemia in Type 1 Diabetes Mellitus.
    Diabetes. 2026 Jul 1:db260293. doi: 10.2337/db26-0293.
    

    >> Share

    
    June 2026
12. CRITCHLEY JA, Carey IM, Chaudhry UAR, Bowen L, et al
    Increased Risk of Infections in People Living With Diabetes.
    Diabetes. 2026 Jun 6:dbi260004. doi: 10.2337/dbi26-0004.
    

    >> Share

    
    
13. KING AN, Ussher JR
    Focusing on Diastolic Dysfunction to Achieve Consensus With the Term Diabetic Cardiomyopathy.
    Diabetes. 2026 Jun 6:dbi260002. doi: 10.2337/dbi26-0002.
    

    >> Share

    
    May 2026
14. KOPRIVICA I, Jonic N, Dimitrijevic M, Jevtic B, et al
    Activation of Intestinal Type 3 Innate Lymphoid Cells and Regulatory T Cells Through Free Fatty Acid Receptor 2 Ameliorates Type 1 Diabetes in Mice.
    Diabetes. 2026 May 18:db250742. doi: 10.2337/db25-0742.
    

    >> Share

    
    
15. ONIZUKA S, Shinjo T, Ishikado A, Wu IH, et al
    Protection Against Periodontitis by Improving Mitochondrial Function in Diabetes.
    Diabetes. 2026 May 15:db250849. doi: 10.2337/db25-0849.
    

    >> Share

    
    
16. AMENDOLARA R, De Vita F, Abedi V, Luvera D, et al
    Distinct Interplay Between beta-Cell Function and Insulin Resistance in Latent Autoimmune Diabetes in Adults Versus Type 2 Diabetes.
    Diabetes. 2026 May 11:db250933. doi: 10.2337/db25-0933.
    

    >> Share

    
    
17. SORUM NE, Warnoe J, Holst JJ, Hartmann B, et al
    The Glucagonotropic Effect of GIP Is Negated During Insulin-Induced Hypoglycemia in Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study.
    Diabetes. 2026 May 5:db251128. doi: 10.2337/db25-1128.
    

    >> Share

    
    April 2026
18. DAO GM, Zhao S, Schofield C, Vogrin S, et al
    Whey Protein Ingestion Stimulates Glucagon Secretion and Raises Blood Glucose Levels in Adults With Type 1 Diabetes.
    Diabetes. 2026 Apr 24:db260059. doi: 10.2337/db26-0059.
    

    >> Share

    
    
19. PUGLIESE A
    Distinct Host Responses to Enterovirus in Children With Islet Autoimmunity Provide a New Framework for the Role of Infections in Type 1 Diabetes.
    Diabetes. 2026;75:603-605.
    

    >> Share

    
    March 2026
20. YE J, Qiu Y, Aguilan JT, Sun Y, et al
    The Downregulation of Type 1 Diabetes Susceptibility Gene PGM1 Induces Metabolic Imbalance and Stress in Pancreatic beta-Cells.
    Diabetes. 2026 Mar 31:db250191. doi: 10.2337/db25-0191.
    

    >> Share

    
    
21. DWYER JR, Racine JJ, Chapman HD, Bell A, et al
    Multiple Mechanisms Contribute to Robust Type 1 Diabetes Protection in Nfkbid- Overexpressing NOD Mice.
    Diabetes. 2026 Mar 20:db250956. doi: 10.2337/db25-0956.
    

    >> Share

    
    
22. MONTASER E, Sosenko JM, Ismail HM
    Predicting the Timing of the Metabolic Inflection Point in Type 1 Diabetes Progression Using Machine Learning and Survival Analysis Models.
    Diabetes. 2026 Mar 20:db250961. doi: 10.2337/db25-0961.
    

    >> Share

    
    
23. SAKAKI K, Murakami T, Yoshida H, Otani D, et al
    Quantitative beta-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.
    Diabetes. 2026 Mar 12:db251127. doi: 10.2337/db25-1127.
    

    >> Share

    
    February 2026
24. BONFIELD G, Russ-Silsby J, Ramchand S, Luckett AM, et al
    Biallelic Pathogenic Variants in IL2RA Cause Neonatal-Onset Monogenic Autoimmune Diabetes.
    Diabetes. 2026 Feb 27:db250885. doi: 10.2337/db25-0885.
    

    >> Share

    
    
25. RAINERI D, Savastio S, Bellone S, Scotti L, et al
    Memory Regulatory T Cells as a Biomarker of Early Type I Diabetes.
    Diabetes. 2026 Feb 23:db250161. doi: 10.2337/db25-0161.
    

    >> Share

    
    
26. DELGADO-CORRALES B, Fingerhut L, Leung P, Yau CSA, et al
    Distinct Enterovirus Antigen Landscape in Children With Islet Autoimmunity.
    Diabetes. 2026 Feb 9:db250805. doi: 10.2337/db25-0805.
    

    >> Share

    
    January 2026
27. GREENBAUM CJ, Long SA, Gitelman SE, Gaglia JL, et al
    Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.
    Diabetes. 2026 Jan 21:db250777. doi: 10.2337/db25-0777.
    

    >> Share

    
    
28. JIA X, Zhang C, Waugh K, Miao D, et al
    Identifying Insulin Autoantibodies With Differential Risk in Type 1 Diabetes With a Novel Bridging ELISA.
    Diabetes. 2026 Jan 12:db250696. doi: 10.2337/db25-0696.
    

    >> Share

    
    
29. OSHIMA M, Halliez C, Kobaisi F, Mode N, et al
    Killing of Human beta-Cells by CD8+ T Cells Triggers Inflammatory Paracrine Signaling and Neighboring beta-Cell Dysfunction.
    Diabetes. 2026;75:124-132.
    

    >> Share

    
    
30. GONCALVES LM, Shirvaikar I, Sideris K, Pereira E, et al
    Microvascular Homeostasis Is Compromised in Pancreatic Islets in a Mouse Model of beta-Cell Loss and Low-Grade Inflammation.
    Diabetes. 2026;75:70-84.
    

    >> Share

    
    December 2025
31. TRIOLO TM, Sosenko JM, Cuthbertson D, Oram RA, et al
    Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression.
    Diabetes. 2025 Dec 10:db250711. doi: 10.2337/db25-0711.
    

    >> Share

    
    
32. ZHAO LP, Papadopoulos GK, Skyler JS, Parikh HM, et al
    Profiling Associations Between IGHG-FCGR Ligand-Receptor Interactions and Disease Progression From Stage 1 and 2 to Stage 3 Type 1 Diabetes.
    Diabetes. 2025 Dec 3:db250610. doi: 10.2337/db25-0610.
    

    >> Share

    
    November 2025
33. WILSON CS, Stocks BT, Falk AC, Moore DJ, et al
    B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes.
    Diabetes. 2025 Nov 25:db250241. doi: 10.2337/db25-0241.
    

    >> Share

    
    
34. RUCHI FNU, Schiavon M, Pandey A, Dalla Man C, et al
    Postprandial Glucagon Metabolism in Healthy and Type 1 Diabetes.
    Diabetes. 2025 Nov 20:db250587. doi: 10.2337/db25-0587.
    

    >> Share

    
    
35. DEUTSCH AJ, Bell AS, Michalek DA, Burkholder AB, et al
    Development and Validation of a Type 1 Diabetes Multi-Ancestry Polygenic Score.
    Diabetes. 2025 Nov 14:db250772. doi: 10.2337/db25-0772.
    

    >> Share

    
    
36. GALDERISI A, Carr ALJ, Taylor P, Bonet J, et al
    Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes.
    Diabetes. 2025 Nov 14:db250801. doi: 10.2337/db25-0801.
    

    >> Share

    
    
37. PITA-GRISANTI V, Martins Pecanha FL, Louzada RA, Blandino-Rosano M, et al
    Protection Against Type 1 Diabetes Development in Mice With 4E-BP2 Deletion.
    Diabetes. 2025 Nov 14:db250348. doi: 10.2337/db25-0348.
    

    >> Share

    
    
38. OROZCO S, Aljobaily N, Reynolds HM, Oceguera GA, et al
    Flt3L-Derived Antigen-Presenting Cell Transfer in Neonatal NOD Mice Reduces the Incidence of Type 1 Diabetes.
    Diabetes. 2025 Nov 6:db250055. doi: 10.2337/db25-0055.
    

    >> Share

    
    
39. BLOM SE, Narsian PR, Behan-Bush RM, Ankrum JA, et al
    Proinflammatory Cytokines Mediate Pancreatic beta-Cell-Specific Alterations to Golgi Integrity via iNOS-Dependent Mitochondrial Inhibition.
    Diabetes. 2025;74:1992-2007.
    

    >> Share

    
    October 2025
40. GROEGLER J, Mangold K, Nicholson K, Dang M, et al
    Strategic Reduction of Hybrid Insulin Peptide Formation Significantly Delays Diabetes Onset in NOD Mice.
    Diabetes. 2025 Oct 21:db250324. doi: 10.2337/db25-0324.
    

    >> Share

    
    
41. HAMPE CS, Kamat V, Bryan CL, Pyle L, et al
    Deleterious Effects of a GAD65 Monoclonal Autoantibody on Islet Function.
    Diabetes. 2025 Oct 10:db250475. doi: 10.2337/db25-0475.
    

    >> Share

    
    September 2025
42. FLAMMER ER, Christopher MW, Powers ER, Broncucia H, et al
    Serum Metabolomics Reveals Potential Differences in Gut Microbiota-Associated Metabolites in Twins Discordant for Type 1 Diabetes.
    Diabetes. 2025 Sep 11:db250156. doi: 10.2337/db25-0156.
    

    >> Share

    
    
43. GILLESPIE KM
    Islet Autoantibody Testing as Type 1 Diabetes Early Detection Enters Mainstream Health Care.
    Diabetes. 2025;74:1466-1468.
    

    >> Share

    
    August 2025
44. SIMS EK, Russell WE, Cuthbertson D, Skyler JS, et al
    Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval.
    Diabetes. 2025 Aug 28:db250310. doi: 10.2337/db25-0310.
    

    >> Share

    
    
45. REYNOLDS KM, Sun Q, Zhang Y, Umans J, et al
    Diabetes Genetic Clusters and Clinical Outcomes in American Indians.
    Diabetes. 2025 Aug 18:db250322. doi: 10.2337/db25-0322.
    

    >> Share

    
    
46. ZHOU X, Iakovliev A, McGurnaghan S, Erabadda B, et al
    Genome-Wide Aggregated Trans Effects Analysis for Circulating Proteins Indicates a Key Role of Immune Checkpoints in Type 1 Diabetes.
    Diabetes. 2025 Aug 11:db250067. doi: 10.2337/db25-0067.
    

    >> Share

    
    July 2025
47. EVANS-MOLINA C, Dor Y, Lernmark A, Mathieu C, et al
    The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetes. 2025 Jul 30:dbi250011. doi: 10.2337/dbi25-0011.
    

    >> Share

    
    
48. DROTAR DM, Vazquez Ramos GJA, Williams MD, David ST, et al
    Loss of Insulin-Positive Cell Clusters Precedes the Decrease in Islet Frequency and beta-Cell Area in Type 1 Diabetes.
    Diabetes. 2025 Jul 24:db250326. doi: 10.2337/db25-0326.
    

    >> Share

    
    
49. MARINAC M, Rickels MR, Gaglia JL, O'Connell PJ, et al
    Future Directions and Clinical Trial Considerations for Novel Islet beta-Cell Replacement Therapies for Type 1 Diabetes.
    Diabetes. 2025 Jul 15:dbi240037. doi: 10.2337/dbi24-0037.
    

    >> Share

    
    
50. WASSERFALL CH, Forsmark CE, Li S, Li L, et al
    Type 1 Diabetes Autoantibodies in Acute, Recurrent Acute, and Chronic Pancreatitis.
    Diabetes. 2025 Jul 9:db240931. doi: 10.2337/db24-0931.
    

    >> Share

    
    June 2025
51. SHEANON N, Warner SO, Dai Y, Whitsett NH, et al
    Fasting Lowers Glucagon Levels Under Basal Conditions and During Insulin-Induced Hypoglycemia in Individuals With Type 1 Diabetes.
    Diabetes. 2025 Jun 30:db250251. doi: 10.2337/db25-0251.
    

    >> Share

    
    
52. GIANFRANI C, Camarca A, Picascia S, Vitale S, et al
    T-Cell Mediated Immunity to Gliadin Is Elicited in the Gut Mucosa of Type 1 Diabetes Patients Only in Presence of Celiac Disease Comorbidity.
    Diabetes. 2025 Jun 24:db241120. doi: 10.2337/db24-1120.
    

    >> Share

    
    
53. BERG-HANSEN K, Bangshaab M, Gopalasingam N, Nielsen R, et al
    The Cardiac and Hemodynamic Effects of Ketone Bodies Are Abnormal in Patients With Type 1 Diabetes: A Randomized Controlled Trial.
    Diabetes. 2025 Jun 17:db250243. doi: 10.2337/db25-0243.
    

    >> Share

    
    
54. PIPELLA J, Motlagh RA, Rampazzo Morelli N, Thompson PJ, et al
    Autoreactive T Cells and Cytokine Stress Drive beta-Cell Senescence Entry and Accumulation in Type 1 Diabetes.
    Diabetes. 2025 Jun 11:db241122. doi: 10.2337/db24-1122.
    

    >> Share

    
    
55. MAURAS N, Ma Q, Weinzimer SA, White NH, et al
    Differences in White Matter Microstructure in Children With Type 1 Diabetes Persist During Longitudinal Follow-up: Relation to Dysglycemia.
    Diabetes. 2025 Jun 2:db240684. doi: 10.2337/db24-0684.
    

    >> Share

    
    
56. AKHBARI P, Perez-Hernandez J, Russell MA, Dhayal S, et al
    Soluble HLA Class I Is Released From Human beta-Cells Following Exposure to Interferons.
    Diabetes. 2025;74:956-968.
    

    >> Share

    
    
57. WATSON TK, Rosen ABI, Drow T, Medjo JA, et al
    Reduced Function of the Adaptor SH2B3 Promotes T1D via Altered Cytokine-Regulated, T-Cell-Intrinsic Immune Tolerance.
    Diabetes. 2025;74:943-955.
    

    >> Share

    
    
58. THOMSON EA, Lee S, Xu H, Moeller H, et al
    Intermittent Low-Magnitude Pressure Applied Across Macroencapsulation Devices Enables Physiological Insulin Delivery Dynamics.
    Diabetes. 2025;74:873-884.
    

    >> Share

    
    
59. BRUCE CR, Ang T, Toms JD, Dao GM, et al
    The Effect of Small Increases in Blood Glucose on Insulin Secretion and Endogenous Glucose Production in Humans.
    Diabetes. 2025;74:898-906.
    

    >> Share

    
    May 2025
60. RUCHI FNU, Schiavon M, Yadav Y, Dalla Man C, et al
    Splanchnic and Leg Glucagon Metabolism in Healthy and Type 1 Diabetes: First in Human Study Using [13C9, 15N1]-Glucagon.
    Diabetes. 2025 May 30:db241064. doi: 10.2337/db24-1064.
    

    >> Share

    
    
61. FAN KS, Shojaee-Moradie F, Jeivad F, Manoli A, et al
    A Dual Stable Isotope Study of the Effect of Altitude and Simulated Flight on Glucose Metabolism in Type 1 Diabetes: A Randomized Crossover Study.
    Diabetes. 2025 May 28:db250004. doi: 10.2337/db25-0004.
    

    >> Share

    
    
62. WILLIAMS JM, Hilmes MA, Letourneau-Freiberg LR, Kandasamy B, et al
    Smaller Pancreas Volume in Insulin-Dependent Monogenic Diabetes.
    Diabetes. 2025 May 22:db250318. doi: 10.2337/db25-0318.
    

    >> Share

    
    
63. FLATT AJ, Matus AM, Gallop RJ, Markmann E, et al
    beta-Cell Secretory Capacity Predicts Metabolic Outcomes Over 6 Years After Human Islet Transplantation.
    Diabetes. 2025;74:749-759.
    

    >> Share

    
    April 2025
64. HERING BJ, Rickels MR, Bellin MD, Millman JR, et al
    Advances in Cell Replacement Therapies for Diabetes.
    Diabetes. 2025 Apr 24:db250037. doi: 10.2337/db25-0037.
    

    >> Share

    
    
65. PARENT AV, Agarwal A, Alvarez-Dominguez JR, Arrojo E Drigo R, et al
    Closing the Gap Between Vision and Victory in Type 1 Diabetes: The NIDDK Human Islet Research Network (HIRN) Initiative.
    Diabetes. 2025 Apr 24:db250097. doi: 10.2337/db25-0097.
    

    >> Share

    
    
66. JONES TLZ, Kusmartseva I, Litovsky S, Thakar R, et al
    The Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D): An NIDDK Initiative to Advance Understanding of Mechanisms Underlying Cardiovascular Disease in Type 1 Versus Type 2 Diabetes.
    Diabetes. 2025 Apr 24:db250017. doi: 10.2337/db25-0017.
    

    >> Share

    
    
67. ISMAIL HM, Cuthbertson D, Galderisi A, Libman I, et al
    The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes.
    Diabetes. 2025 Apr 2:db241000. doi: 10.2337/db24-1000.
    

    >> Share

    
    
68. BILAL A, Casu A, Yi F, Dutta T, et al
    A Randomized-Controlled, Double-Masked Cross-Over Study of a GPR119 Agonist on Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes.
    Diabetes. 2025 Apr 2:db250096. doi: 10.2337/db25-0096.
    

    >> Share

    
    March 2025
69. KRISCHER JP, Muller S, You L, Achenbach P, et al
    A Comparative Analysis of the Sensitivity, Specificity, Concordance, and the 5-year Predictive Power of Diabetes-related Autoantibody Assays.
    Diabetes. 2025 Mar 10:db240814. doi: 10.2337/db24-0814.
    

    >> Share

    
    February 2025
70. LEE J, Ustione A, Wilkerson EM, Balakrishnan R, et al
    Regulation of Type 1 Diabetes via Brown Adipocyte-Secreted Proteins and the Novel Glucagon Regulator Nidogen-2.
    Diabetes. 2025 Feb 28:db241003. doi: 10.2337/db24-1003.
    

    >> Share

    
    January 2025
71. JIA X, Wenzlau JM, Zhang C, Dong F, et al
    Strong Association of Autoantibodies Targeting Deamidated Extracellular Epitopes of Insulinoma Antigen-2 (IA-2) with Clinical Onset of Type 1 Diabetes.
    Diabetes. 2025 Jan 16:db240571. doi: 10.2337/db24-0571.
    

    >> Share

    
    
72. HOHENSTEIN AC, Gallegos J, Dang M, Groegler J, et al
    Novel T Cell reactivities to Hybrid Insulin Peptides in Islet Autoantibody-Positive At-Risk Subjects.
    Diabetes. 2025 Jan 16:db240611. doi: 10.2337/db24-0611.
    

    >> Share

    
    
73. LU T, Manousaki D, Sun L, Paterson AD, et al
    Integrative proteogenomic analyses provide novel interpretations of type 1 diabetes risk loci through circulating proteins.
    Diabetes. 2025 Jan 6:db240380. doi: 10.2337/db24-0380.
    

    >> Share

    
    
74. YANG WX, Su K, Liao MC, Zhou J, et al
    Renal Tubule-Specific Angiotensinogen Deletion Attenuates SGLT2 Expression and Ameliorates Diabetic Kidney Disease in Murine Models of Type 1 Diabetes.
    Diabetes. 2025 Jan 3:db240553. doi: 10.2337/db24-0553.
    

    >> Share

    
    November 2024
75. NG STH, Price MJ, Richardson N, Nawaf M, et al
    Pre-clinical development of a tolerogenic peptide from glutamate decarboxylase as a candidate for antigen-specific immunotherapy in type 1 diabetes.
    Diabetes. 2024 Nov 21:db230996. doi: 10.2337/db23-0996.
    

    >> Share

    
    
76. ROSHANDEL D, Spiliopoulou A, McGurnaghan SJ, Iakovliev A, et al
    Genetics of C-peptide and Age at Diagnosis in Type 1 Diabetes.
    Diabetes. 2024 Nov 18:db240340. doi: 10.2337/db24-0340.
    

    >> Share

    
    
77. MCNITT DH, Williams JM, Santitoro JG, Kim J, et al
    Type 1 diabetes depends on CD4-driven expression of the transcriptional repressor, Bcl6.
    Diabetes. 2024 Nov 18:db230709. doi: 10.2337/db23-0709.
    

    >> Share

    
    
78. LUCKETT AM, Hawkes G, Green HD, De Franco E, et al
    Type 1 diabetes genetic risk contributes to phenotypic presentation in monogenic autoimmune diabetes.
    Diabetes. 2024 Nov 12:db240485. doi: 10.2337/db24-0485.
    

    >> Share

    
    October 2024
79. MALLONE R, Sims E, Achenbach P, Mathieu C, et al
    Emerging concepts and success stories in type 1 diabetes research: a roadmap for a bright future.
    Diabetes. 2024 Oct 24:db240439. doi: 10.2337/db24-0439.
    

    >> Share

    
    
80. BARRA JM, Kratz AT, Castro-Gutierrez R, Proia J, et al
    Cryopreservation of Stem Cell-Derived beta-Like Cells Enriches for Insulin-Producing Cells With Improved Function.
    Diabetes. 2024;73:1687-1696.
    

    >> Share

    
    September 2024
81. ALMUTAIRI A, White TD, Stephenson DJ, Stephenson BD, et al
    Selective Reduction of Ca2+-Independent Phospholipase A2beta (iPLA2beta)-Derived Lipid Signaling from Macrophages Mitigates Type 1 Diabetes Development.
    Diabetes. 2024 Sep 16:db230770. doi: 10.2337/db23-0770.
    

    >> Share

    
    
82. LIU Y, Wang S, Wang Z, Yu J, et al
    Recent Progress in Glucose-Responsive Insulin.
    Diabetes. 2024;73:1377-1388.
    

    >> Share

    
    August 2024
83. GREENBAUM CJ, Nepom GT, Wood-Heickman LK, Wherrett DK, et al
    Evolving Concepts in Pathophysiology, Screening, and Prevention of Type 1 Diabetes: Report of Diabetes Mellitus Interagency Coordinating Committee Workshop.
    Diabetes. 2024 Aug 21:dbi240020. doi: 10.2337/dbi24-0020.
    

    >> Share

    
    
84. SHEN Y, Shi R, Lu S, Wang Y, et al
    Role of Peptidyl arginine deiminase 4-dependent macrophage extracellular traps formation on Type 1 Diabetes pathogenesis.
    Diabetes. 2024 Aug 13:db231000. doi: 10.2337/db23-1000.
    

    >> Share

    
    
85. MARTINO M, Galderisi A, Evans-Molina C, Dayan C, et al
    Revisiting the pattern of loss of beta-cell function in preclinical Type 1 Diabetes.
    Diabetes. 2024 Aug 6:db240163. doi: 10.2337/db24-0163.
    

    >> Share

    
    July 2024
86. MANDUCHI E, Descamps HC, Schug J, Da T, et al
    No evidence for persistent enteroviral B infection of pancreatic islets in type 1 diabetic and pre-diabetic patients from RNA-Seq data.
    Diabetes. 2024 Jul 31:db240076. doi: 10.2337/db24-0076.
    

    >> Share

    
    
87. GRACE SL, Gillespie KM, Williams CL, Lampasona V, et al
    Autoantibodies to truncated GAD(96-585) antigen stratify risk of early insulin requirement in adult-onset diabetes.
    Diabetes. 2024 Jul 8:db230980. doi: 10.2337/db23-0980.
    

    >> Share

    
    
88. SUNILKUMAR S, Dennis MD
    REDD1 is a Promising Therapeutic Target to Combat the Development of Diabetic Complications: A Report on Research Supported by Pathway to Stop Diabetes.
    Diabetes. 2024 Jul 8:dbi240013. doi: 10.2337/dbi24-0013.
    

    >> Share

    
    
89. KJELDSEN SAS, Richter MM, Jensen NJ, Nilsson MSD, et al
    Glucagon resistance in individuals with obesity and hepatic steatosis can be measured using the GLUSENTIC test and index.
    Diabetes. 2024 Jul 8:db230858. doi: 10.2337/db23-0858.
    

    >> Share

    
    
90. SCHRODERUS AM, Pitkanen V, Ekman I, Stevens D, et al
    Temporal Alterations in CD8+ T Cells During the Progression from Stage 1 to Stage 3 Type 1 Diabetes.
    Diabetes. 2024 Jul 5:db240159. doi: 10.2337/db24-0159.
    

    >> Share

    
    June 2024
91. LESLIE KA, Lekka C, Richardson SJ, Russell MA, et al
    Regulation of STAT1 signalling in human pancreatic beta-cells by the lysine deacetylase, HDAC6; a new therapeutic opportunity in type 1 diabetes?
    Diabetes. 2024 Jun 13:db240008. doi: 10.2337/db24-0008.
    

    >> Share

    
    May 2024
92. YANG Z, Zhang Z, Li L, Jing Z, et al
    Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-onset Type 1 Diabetes.
    Diabetes. 2024 May 21:db230987. doi: 10.2337/db23-0987.
    

    >> Share

    
    
93. FRORUP C, Jensen MH, Haupt-Jorgensen M, Buschard K, et al
    Elevated cathepsin S serum levels in new-onset type 1 diabetes and autoantibody-positive siblings.
    Diabetes. 2024 May 3:db230911. doi: 10.2337/db23-0911.
    

    >> Share

    
    April 2024
94. EVANS-MOLINA C
    The Ailing beta-Cell in Diabetes: Insights From a Trip to the ER: The 2023 Outstanding Scientific Achievement Award Lecture.
    Diabetes. 2024;73:545-553.
    

    >> Share

    
    
95. DRAWSHY Z, Neiman D, Fridlich O, Peretz A, et al
    DNA Methylation-Based Assessment of Cell Composition in Human Pancreas and Islets.
    Diabetes. 2024;73:554-564.
    

    >> Share

    
    March 2024
96. KIM YK, Kim YR, Wells KL, Sarbaugh D, et al
    PTPN2 Regulates Metabolic Flux to Affect beta-Cell Susceptibility to Inflammatory Stress.
    Diabetes. 2024;73:434-447.
    

    >> Share

    
    February 2024
97. KASINATHAN D, Guo Z, Sarver DC, Wong GW, et al
    Cell-surface ZnT8 antibody prevents and reverses autoimmune diabetes in mice.
    Diabetes. 2024 Feb 22:db230568. doi: 10.2337/db23-0568.
    

    >> Share

    
    
98. CALLEBAUT A, Guyer P, Derua R, Buitinga M, et al
    CD4+ T cells from individuals with type 1 diabetes respond to a novel class of deamidated peptides formed in pancreatic islets.
    Diabetes. 2024 Feb 22:db230588. doi: 10.2337/db23-0588.
    

    >> Share

    
    
99. LATRES E, Greenbaum CJ, Oyaski ML, Dayan CM, et al
    Evidence for C-peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes.
    Diabetes. 2024 Feb 13:dbi230012. doi: 10.2337/dbi23-0012.
    

    >> Share

    
    January 2024
100. CALLEBAUT A, Guyer P, Baker RL, Gallegos JB, et al
     An Insulin-Chromogranin A Hybrid Peptide activates DR11 restricted T cells in human type 1 diabetes.
     Diabetes. 2024 Jan 31:db230622. doi: 10.2337/db23-0622.
     

     >> Share

     
     
101. CIOU JJ, Chien MW, Hsu CY, Liu YW, et al
     Excess Salt Intake Activates IL-21-dominant Autoimmune Diabetogenesis via A Saltregulated Ste20-related Proline/alanine-rich Kinase in CD4 T Cells.
     Diabetes. 2024 Jan 19:db230599. doi: 10.2337/db23-0599.
     

     >> Share

     
     
102. WYATT RC, Grace SL, Brigatti C, Marzinotto I, et al
     Improved specificity of glutamate decarboxylase 65 autoantibody measurement using luciferase-based immunoprecipitation system (LIPS) assays.
     Diabetes. 2024 Jan 17:db230550. doi: 10.2337/db23-0550.
     

     >> Share

     
     November 2023
103. KUGATHASAN L, Sridhar VS, Lovblom LE, Matta S, et al
     Interactive effects of Empagliflozin and Hyperglycemia on Urinary Amino Acids in Individuals with Type 1 Diabetes.
     Diabetes. 2023 Nov 28:db230694. doi: 10.2337/db23-0694.
     

     >> Share

     
     
104. LAI SWT, Hernandez-Castillo C, De Jesus Lopez Gonzalez E, Zoukari T, et al
     Methylglyoxal adducts are prognostic biomarkers for diabetic kidney disease in patients with type 1 diabetes.
     Diabetes. 2023 Nov 15:db230277. doi: 10.2337/db23-0277.
     

     >> Share

     
     
105. ILONEN J, Kiviniemi M, El-Amir MI, Nygard L, et al
     Increased Frequency of the HLA-DRB1*04:04-DQA1*03-DQB1*03:02 Haplotype among HLA-DQB1*06:02 Positive Children with Type 1 Diabetes.
     Diabetes. 2023 Nov 7:db230387. doi: 10.2337/db23-0387.
     

     >> Share

     
     
106. ELGAMAL RM, Kudtarkar P, Melton RL, Mummey HM, et al
     An Integrated Map of Cell Type-Specific Gene Expression in Pancreatic Islets.
     Diabetes. 2023;72:1719-1728.
     

     >> Share

     
     
107. THIRAWATANANOND P, Brown ME, Sachs LK, Arnoletti JM, et al
     Treg-Specific CD226 Deletion Reduces Diabetes Incidence in NOD Mice by Improving Regulatory T-Cell Stability.
     Diabetes. 2023;72:1629-1640.
     

     >> Share

     
     October 2023
108. WRIGHT JJ, Eskaros A, Windon A, Bottino R, et al
     Exocrine pancreas in type 1 and type 2 diabetes: different patterns of fibrosis, metaplasia, angiopathy, and adiposity.
     Diabetes. 2023 Oct 26:db230009. doi: 10.2337/db23-0009.
     

     >> Share

     
     
109. ZOU W, Chezhian J, Yu T, Liu W, et al
     Dissecting the roles of the nuclear and mitochondrial genomes in a mouse model of autoimmune diabetes.
     Diabetes. 2023 Oct 17:db230430. doi: 10.2337/db23-0430.
     

     >> Share

     
     
110. XU G, Chen J, Lu B, Sethupathy P, et al
     Verapamil Prevents Decline of IGF-I in Subjects With Type 1 Diabetes and Promotes beta-Cell IGF-I Signaling.
     Diabetes. 2023;72:1460-1469.
     

     >> Share

     
     September 2023
111. OBERHAUSER SS, l'Allemand D, Willems EP, Gozzi T, et al
     The slowing of peripheral nerve conduction velocity in children and adolescents with type 1 diabetes is predicted by glucose fluctuations.
     Diabetes. 2023 Sep 12:db230063. doi: 10.2337/db23-0063.
     

     >> Share

     
     July 2023
112. SASSI G, Licata G, Ventriglia G, Wouters A, et al
     A plasma miR-193b-365 signature combined with age and glycemic status predicts response to Lactococcus lactis-based antigen-specific immunotherapy in new-onset type 1 diabetes.
     Diabetes. 2023 Jul 26:db220852. doi: 10.2337/db22-0852.
     

     >> Share

     
     
113. WRETLIND A, Curovic VR, Suvitaival T, Theilade S, et al
     Ceramides as risk markers for future cardiovascular events and all-cause mortality in long-standing type 1 diabetes.
     Diabetes. 2023 Jul 21:db230052. doi: 10.2337/db23-0052.
     

     >> Share

     
     
114. SCHON M, Zaharia OP, Strassburger K, Kupriyanova Y, et al
     Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type 2 Diabetes Mellitus.
     Diabetes. 2023 Jul 21:db230353. doi: 10.2337/db23-0353.
     

     >> Share

     
     
115. TANG Y, Ang L, Jaiswal M, Dillon BR, et al
     Cardiovascular autonomic neuropathy and risk of kidney function decline in type 1 and type 2 diabetes: findings from the PERL and ACCORD cohorts.
     Diabetes. 2023 Jul 19:db230247. doi: 10.2337/db23-0247.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share